Mesco Pharmaceuticals Ltd. reported unaudited earnings results for the second quarter and six months ended September 30, 2017. For the quarter, the company reported loss before exceptional items and tax finance costs & exceptional items was INR 126,439.00 compared INR 78,597.00 a year ago. Loss before tax was INR 126,439 compared to INR 78,597 a year ago. Loss for the period was INR 126,439 compared to INR 78,597 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.01 per share compared to INR 0.00 a year ago. For the six months, the company reported loss before exceptional items and tax finance costs & exceptional items was INR 636,944.00 compared INR 153,565.00 a year ago. Loss before tax was INR 636,944 compared to INR 153,565 a year ago. Loss for the period was INR 636,944 compared to INR 153,565 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.03 per share compared to INR 0.01 a year ago.